ACOR - Acorda Therapeutics Stock Trading
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
INBRIJA ® (levodopa inhalation powder) Q1 2021 net revenue of $5 million; 13% increase over Q1 2020 INBRIJA organic growth (dispensed cartons) was 25% Q1 2021 over Q1 2020 AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg Q1 2021 net revenue of $2...
-
#Investors in Acorda Therapeutics (NASDAQ: ACOR) like to make good #decisions, that means they like to #buyandsell at the right times, and to do that the best tools involve charts, pivot points, and the technical data. Below, we have provided a snapshot for ACOR that ...
-
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2021 update and financial results on Thursday, May 6 at 4:30 p.m. ET. To participate in the Webcast/Conference Call, please note there is a new pre-registration pro...